Nothing Special   »   [go: up one dir, main page]

MESSINIS et al., 1990 - Google Patents

Superovulation induction in women suppresses luteinizing hormone secretion at the pituitary level

MESSINIS et al., 1990

Document ID
4647989625585807379
Author
MESSINIS I
TEMPLETON A
Publication year
Publication venue
Clinical endocrinology

External Links

Snippet

In superovulated women the pituitary response to GnRH is markedly attenuated by an unspecified ovarian factor (s). To examine the site of attenuation, the response of the pituitary to GnRH was investigated in five normally ovulating women during the late follicular …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone

Similar Documents

Publication Publication Date Title
MESSINIS et al. Endogenous luteinizing hormone surge during superovulation induction with sequential use of clomiphene citrate and pulsatile human menopausal gonadotropin
Itskovitz et al. Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist
Martin et al. Comparison of exogenous gonadotropins and pulsatile gonadotropin-releasing hormone for induction of ovulation in hypogonadotropic amenorrhea
Shoham et al. Results of ovulation induction using human menopausal gonadotropin or purified follicle-stimulating hormone in hypogonadotropic hypogonadism patients
Mishell Jr et al. Serum estradiol in women ingesting combination oral contraceptive steroids
ZELEZNIK et al. Ovarian responses in macaques to pulsatile infusion of follicle-stimulating hormone (FSH) and luteinizing hormone: increased sensitivity of the maturing follicle to FSH
Macnamee et al. Short-term luteinizing hormone-releasing hormone agonist treatment: prospective trial of a novel ovarian stimulation regimen for in vitro fertilization
Luukkainen et al. Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486
Ben-Rafael et al. Differences in ovarian stimulation in human menopausal gonadotropin treated woman may be related to follicle-stimulating hormone accumulation
Japan A role for thyroid hormone in the induction of ovulation and corpus luteum function
Matsuzaki et al. Mechanism of anovulation in hyperprolactinemic amenorrhea determined by pulsatile gonadotropin-releasing hormone injection combined with human chorionic gonadotropin
WINTERS et al. A reexamination of pulsatile luteinizing hormone secretion in primary testicular failure
Kauppila et al. Hypoprolactinemia and ovarian function
Tsuiki et al. Steroid profiles of follicular fluids from a patient with the empty follicle syndrome
Messinis et al. Attenuation of gonadotrophin release and reserve in superovulated women by gonadotrophin surge attenuating factor (GnSAF)
Messinis et al. The importance of follicle-stimulating hormone increase for folliculogenesis
Lolis et al. The follicle-stimulating hormone threshold level for follicle maturation in superovulated cycles
MESSINIS et al. Superovulation induction in women suppresses luteinizing hormone secretion at the pituitary level
Adonakis et al. Luteinizing hormone increases estradiol secretion but has no effect on progesterone concentrations in the late follicular phase of in vitro fertilization cycles in women treated with gonadotropin-releasing hormone agonist and follicle-stimulating hormone
Messinis et al. THE EFFECT OF PULSATILE FOLLICLE STIMULATING HORMONE ON THE. ENDOGENOUS LUTEINIZING HORMONE SURGE IN WOMEN
MESSINIS et al. Blockage of the positive feedback effect of oestradiol during prolonged administration of clomiphene citrate to normal women
MESSINIS et al. In‐vivo bioactivity of gonadotrophin surge attenuating factor (GnSAF)
Templeton et al. Characteristics of ovarian follicles in spontaneous and stimulated cycles in which there was an endogenous luteinizing hormone surge
Davidson et al. Atrial natriuretic peptide, plasma renin activity, and aldosterone in women on estrogen therapy and with premenstrual syndrome
Balmaceda et al. The effects of an LH-RH antagonist ([N-Ac-D-Trp1, 3, Dp-Cl-Phe2, D-Phe6, D-Ala10]-LH-RH) during the preovulatory period of the rhesus monkey